Li, Xiaoli
Liu, Yuyan
Zhu, Minhui
He, Cuixia
Xu, Yuanyuan
Ding, Jiaxiang
Wang, Ying
Shan, Rongfang
Liu, Bingyan
Ding, Yuzhou
Xie, Jing
Zhou, Huan
Wang, Zhiqiang
Liu, Yuanyuan
Funding for this research was provided by:
512 Talent Fund” of Bengbu Medical College (BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China, BY51201313, China)
Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd (2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043, 2021043)
Article History
Received: 6 February 2023
Accepted: 27 March 2023
First Online: 2 May 2023
Declarations
:
: We confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
: This study was conducted in accordance with the Declaration of Helsinki. The protocol was approved by the institutional review boards of all participating sites.
: Written informed consent was obtained from all the participants included in the study.
: Permission to submit the manuscript for publication was obtained from all named authors.